Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting, 7484 [2015-02693]

Download as PDF 7484 Federal Register / Vol. 80, No. 27 / Tuesday, February 10, 2015 / Notices Need and Use of Information Collection: This partnership between NCI and FDA will include assessing the public’s knowledge of medical devices, communications related to product recalls, nutritional supplement labeling, and topics to inform FDA’s regulatory authority over tobacco, such as such as risk perceptions about new tobacco products, product pack color gradations, comprehensive assessment of the American public’s current access to, and use of, information about cancer across the cancer care continuum from cancer prevention, early detection, diagnosis, treatment, and survivorship. OMB approval is requested for 1 year. There are no costs to respondents other than their time. The total estimated annualized burden hours are 2,159. perceptions of product harm, and tobacco product claims and labels. This HINTS survey will couple knowledgerelated questions with inquiries into the communication channels through which understanding is being obtained, and assessment of FDA-regulated material. This survey will extend the information collected and priorities from HINTS which have been to provide a ESTIMATED ANNUALIZED BURDEN HOURS Type of respondents Number of respondents Number of responses per respondent Average burden per response (in hours) Total annual burden hour Individuals ........................................................................................................ 4,318 1 30/60 2,159 Dated: February 4, 2015. Karla Bailey, NCI Project Clearance Liaison, National Institutes of Health. [FR Doc. 2015–02691 Filed 2–9–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on April 8–9, 2015. The topic for this meeting will be ‘‘Opportunities for Research Supported by the Special Statutory Funding Program for Type 1 Diabetes Research.’’ The meeting is open to the public. DATES: The meeting will be held on April 8, 2015 from 8:00 a.m. to 5:45 p.m. and on April 9, 2015 from 8:00 a.m. to 4:45 p.m. ADDRESSES: The meeting will be held at the NIH Neuroscience Center, Conference Room C (April 8) and Conference Room A1/A2 (April 9), 6001 Executive Boulevard, Rockville, MD 20852. Non-federal individuals planning to attend the workshop should register by email to Denise Hoffman, The Scientific Consulting Group, Inc. (dhoffman@scgcorp.com; please put ‘‘Registration DMICC T1D Meeting’’ in the subject line) at least 7 days prior to the workshop. FOR FURTHER INFORMATION CONTACT: An agenda for the DMICC meeting will be available by contacting Denise Hoffman, The Scientific Consulting Group, Inc. (dhoffman@scgcorp.com; please put ‘‘Agenda Request for DMICC T1D Meeting’’ in the subject line). For further rljohnson on DSK3VPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:57 Feb 09, 2015 Jkt 235001 information concerning this meeting, contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes Mellitus Interagency Coordinating Committee, National Institute of Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 31A, Room 9A19, MSC 2560, Bethesda, MD 20892– 2560, telephone: 301–496–6623; FAX: 301–480–6741; email: dmicc@ mail.nih.gov. SUPPLEMENTARY INFORMATION: The DMICC, chaired by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) comprising members of the Department of Health and Human Services and other federal agencies that support diabetes-related activities, facilitates cooperation, communication, and collaboration on diabetes among government entities. DMICC meetings, held several times a year, provide an opportunity for Committee members to learn about and discuss current and future diabetes programs in DMICC member organizations and to identify opportunities for collaboration. The April 8–9, 2015 DMICC meeting will focus on ‘‘Opportunities for Research Supported by the Special Statutory Funding Program for Type 1 Diabetes Research.’’ Any interested person may file written comments with the Committee by forwarding their statement to the contact person listed on this notice. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Because of time constraints for the meeting, there will not be time on the agenda for oral comments from members of the public. Members of the public who would like to receive email notification about future DMICC meetings should register PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 for the listserv available on the DMICC Web site, www.diabetescommittee.gov. Date: February 4, 2015. B. Tibor Roberts, Executive Secretary, DMICC, Office of Scientific Program and Policy Analysis, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. [FR Doc. 2015–02693 Filed 2–9–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Program project: Center for Integrative Biomedical Computing. Date: February 17–19, 2015. Time: 7:00 p.m. to 11:00 a.m. Agenda: To review and evaluate grant applications. Place: Sheraton Salt Lake City, 150 West 500 South, Salt Lake, UT 84101. Contact Person: Marie-Jose Belanger, Ph.D., Scientific Review Officer, Center for Scentific E:\FR\FM\10FEN1.SGM 10FEN1

Agencies

[Federal Register Volume 80, Number 27 (Tuesday, February 10, 2015)]
[Notices]
[Page 7484]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-02693]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Diabetes Mellitus Interagency Coordinating Committee 
Meeting

SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee 
(DMICC) will hold a meeting on April 8-9, 2015. The topic for this 
meeting will be ``Opportunities for Research Supported by the Special 
Statutory Funding Program for Type 1 Diabetes Research.'' The meeting 
is open to the public.

DATES: The meeting will be held on April 8, 2015 from 8:00 a.m. to 5:45 
p.m. and on April 9, 2015 from 8:00 a.m. to 4:45 p.m.

ADDRESSES: The meeting will be held at the NIH Neuroscience Center, 
Conference Room C (April 8) and Conference Room A1/A2 (April 9), 6001 
Executive Boulevard, Rockville, MD 20852. Non-federal individuals 
planning to attend the workshop should register by email to Denise 
Hoffman, The Scientific Consulting Group, Inc. (dhoffman@scgcorp.com; 
please put ``Registration DMICC T1D Meeting'' in the subject line) at 
least 7 days prior to the workshop.

FOR FURTHER INFORMATION CONTACT: An agenda for the DMICC meeting will 
be available by contacting Denise Hoffman, The Scientific Consulting 
Group, Inc. (dhoffman@scgcorp.com; please put ``Agenda Request for 
DMICC T1D Meeting'' in the subject line). For further information 
concerning this meeting, contact Dr. B. Tibor Roberts, Executive 
Secretary of the Diabetes Mellitus Interagency Coordinating Committee, 
National Institute of Diabetes and Digestive and Kidney Diseases, 31 
Center Drive, Building 31A, Room 9A19, MSC 2560, Bethesda, MD 20892-
2560, telephone: 301-496-6623; FAX: 301-480-6741; email: 
dmicc@mail.nih.gov.

SUPPLEMENTARY INFORMATION: The DMICC, chaired by the National Institute 
of Diabetes and Digestive and Kidney Diseases (NIDDK) comprising 
members of the Department of Health and Human Services and other 
federal agencies that support diabetes-related activities, facilitates 
cooperation, communication, and collaboration on diabetes among 
government entities. DMICC meetings, held several times a year, provide 
an opportunity for Committee members to learn about and discuss current 
and future diabetes programs in DMICC member organizations and to 
identify opportunities for collaboration. The April 8-9, 2015 DMICC 
meeting will focus on ``Opportunities for Research Supported by the 
Special Statutory Funding Program for Type 1 Diabetes Research.''
    Any interested person may file written comments with the Committee 
by forwarding their statement to the contact person listed on this 
notice. The statement should include the name, address, telephone 
number and, when applicable, the business or professional affiliation 
of the interested person. Because of time constraints for the meeting, 
there will not be time on the agenda for oral comments from members of 
the public.
    Members of the public who would like to receive email notification 
about future DMICC meetings should register for the listserv available 
on the DMICC Web site, www.diabetescommittee.gov.

    Date: February 4, 2015.
B. Tibor Roberts,
Executive Secretary, DMICC, Office of Scientific Program and Policy 
Analysis, National Institute of Diabetes and Digestive and Kidney 
Diseases, National Institutes of Health.
[FR Doc. 2015-02693 Filed 2-9-15; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.